Best Measure of Ischemic Penumbra: Positron Emission Tomography
2003; Lippincott Williams & Wilkins; Volume: 34; Issue: 10 Linguagem: Inglês
10.1161/01.str.0000092396.70827.28
ISSN1524-4628
Autores Tópico(s)Advanced MRI Techniques and Applications
ResumoHomeStrokeVol. 34, No. 10Best Measure of Ischemic Penumbra: Positron Emission Tomography Free AccessArticle CommentaryPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessArticle CommentaryPDF/EPUBBest Measure of Ischemic Penumbra: Positron Emission Tomography W.-D. Heiss W.-D. HeissW.-D. Heiss From the Max Planck Institute for Neurological Research, Köln, Germany. Originally published11 Sep 2003https://doi.org/10.1161/01.STR.0000092396.70827.28Stroke. 2003;34:2534–2535Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: September 11, 2003: Previous Version 1 The ischemic penumbra was defined by Astrup et al1 as brain tissue perfused at a level within the thresholds of functional impairment and morphological integrity, which has the capacity to recover if perfusion is improved. Because tolerance of tissue to ischemic damage is dependent on residual flow and duration of flow disturbance,2 the ischemic penumbra characterizes a transient condition: it exists for a short period even in the center of ischemia, and may extend to increasing time periods in the more or less hypoperfused surrounding tissue. The concept of the ischemic penumbra has been developed from animal experiments in which regional flow measurements could be clearly related to the functional/morphological state of the tissue. Its transfer to the clinical situation requires the definition of 3 critical values that usually cannot be assessed in the acute stage of ischemic stroke: (1) quantitation of flow in the core and the periphery of the territory with impaired blood supply; (2) state of the various tissue compartments within the affected area with respect to irreversibly damaged or preserved morphology; and (3) the time period the respective tissue compartments have been exposed to more or less severe hypoperfusion. As all clinically available methods at best yield only momentary assessments of brain perfusion and tissue condition at several hours after the vascular attack, the development of these changes over time remains obscure, and predictions on the fate of the tissue from the measurable variables must be vague. Therefore, the definition of penumbra tissue in the clinical setting is limited to accurate assessments of perfusion in the core, the periphery and the surrounding of the territory with impaired blood supply, and the detection of irreversibly damaged tissue at the time of investigation.Positron emission tomography (PET) was leading in the clinical assessment of the penumbra: multitracer studies defined the penumbra as tissue with reduced cerebral blood flow (CBF) but preserved oxygen consumption (CMRO2) and raised oxygen extraction fraction (OEF).3,4 For the definition of irreversible tissue damage at the time of investigation (usually several hours after the ischemic event), the cerebral metabolic rate for oxygen (CMRO2) is the most reliable parameter with ≈65 μmol · 100 g−1 · min−1 as the threshold. In the studies relating early CBF and CMRO2 measurements to infarcts determined on late CT, a flow threshold of 12 mL · 100 g−1 · min−1 was described, which also predicted irreversible damage. These determinations of flow and energy metabolism, however, require complex logistics for investigations of acute stroke patients and necessitate arterial blood sampling, and therefore are difficult to perform in the clinical setting and prohibited when invasive therapies, eg, thrombolysis, are planned. Therefore, tracers are required that indicate tissue integrity or hypoxia, and in combination with semiquantitative determinations of perfusion can outline noninvasively the extent of penumbra tissue. The central benzodiazepine receptor ligand flumazenil (FMZ) labeled with 11-C is a marker of integrity and detects neuronal damage in the cortex in the first hours after ischemic stroke. The extent of decreased accumulations of this tracer in the cortex correlates significantly with the extent of tissue with CMRO2 reduced below the critical threshold and identifies irreversible damage even in areas with increased OEF. Tissue compartments with FMZ binding below a critical threshold cannot benefit from reperfusion—a finding that also supports the ability of the tracer to identify developing infarcts.4In a study in which the final infarcts were analyzed with respect to flow values and FMZ uptake in the first hours after stroke, probability thresholds of FMZ binding and blood flow could be calculated, which predicted the final state of the tissue and defined the range of the penumbra.5 As the 95% prediction limit for infarction the FMZ uptake of 3.4 times the average of white matter was found, as the flow range for the penumbra 4.8 to 14.1 μmol · 100 g−1 · min−1 were obtained.Due to the low concentration of benzodiazepine receptors in white matter and basal ganglia, these values apply only to the cortex but still permit a reliable measure of irreversibly damaged and potentially salvageable portions of an ischemically compromised area. These values are comparable to those determined in invasive studies3 if the errors inherent in determinations based on low count rates are taken into consideration.As a tracer of hypoxic viable tissue, 18-F-fluoromisonidazole (FMISO) could also be used to detect ischemic penumbra. Areas with increased FMISO uptake were detected 6.25 to 42.5 hours after stroke. It is maximal in the initial hours after onset, declines with time, and is absent after several days. The areas were usually distributed over the periphery of the infarct identified on the coregistered late CT, but extended into normal tissue adjacent to the infarct in a few cases.6 These findings suggest that FMISO binding is increased in tissue at risk and mirrors the temporal and spatial distribution of penumbra. However, these results need direct calibration by conventional PET measurements. Since reliable detection of FMISO uptake is delayed (>2 hours between tracer injection and imaging), the value of this tracer is limited for therapeutic decisions in the acute phase of ischemic stroke.As long as other imaging modalities do not yield reliable detection of irreversible tissue damage—even diffusion-weighted MRI might be misleading in some cases7—and do not furnish quantitative values of blood flow for the upper limit of penumbra, PET procedures must be considered still the gold standard for the recognition of penumbra. However, PET is limited by the required expensive equipment and the complex logistics involving a multidisciplinary team. Therefore, time has come to calibrate simpler and widely applicable functional imaging procedures—especially diffusion- and perfusion-weighted MRI—on PET in order to make these modalities a reliable tool in the study of acute ischemic stroke.The opinions expressed in this editorial are not necessarily those of the editors or of the American Stroke Association.FootnotesCorrespondence to Prof Dr W.-D. Heiss, Max-Planck-Institut für neurologische Forschung, Gleueler Str. 50, 50931 Köln, Germany. E-mail [email protected] References 1 Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981; 12: 723–725.CrossrefMedlineGoogle Scholar2 Heiss W-D, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol. 1983; 14: 294–301.CrossrefMedlineGoogle Scholar3 Baron J-C. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 1999; 9: 193–201.CrossrefMedlineGoogle Scholar4 Heiss W-D. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 2000; 20: 1276–1293.CrossrefMedlineGoogle Scholar5 Heiss W-D, Kracht LW, Thiel A, Grond M, Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain. 2001; 124: 20–29.CrossrefMedlineGoogle Scholar6 Read SJ, Hirano T, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, Egan GF, Scott AM, Bladin CF, Mckay WJ, Donnan GA. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology. 1998; 51: 1617–1621.CrossrefMedlineGoogle Scholar7 Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000; 47: 462–469.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Yang S and Liu R (2021) Four Decades of Ischemic Penumbra and Its Implication for Ischemic Stroke, Translational Stroke Research, 10.1007/s12975-021-00916-2, 12:6, (937-945), Online publication date: 1-Dec-2021. Berge E and Sandercock P (2019) Specific treatment of acute ischemic stroke Warlow's Stroke, 10.1002/9781118492390.ch13, (587-656) Iwata T, Mori T, Tanno Y, Kasakura S and Yoshioka K (2018) Measurement of oxygen extraction fraction by blood sampling to estimate severe cerebral hemodynamic failure and anticipate cerebral hyperperfusion syndrome following carotid artery stenting, Journal of NeuroInterventional Surgery, 10.1136/neurintsurg-2018-013748, 10:11, (1063-1066), Online publication date: 1-Nov-2018. Lapchak P (2018) Stroke: Cytoprotection, Repair and Regeneration—The Continuum of Patient Care Cellular and Molecular Approaches to Regeneration and Repair, 10.1007/978-3-319-66679-2_1, (3-20), . Catana C (2017) Principles of Simultaneous PET/MR Imaging, Magnetic Resonance Imaging Clinics of North America, 10.1016/j.mric.2017.01.002, 25:2, (231-243), Online publication date: 1-May-2017. Giovannini E, Giovacchini G and Ciarmiello A (2016) Hybrid Imaging in Cerebrovascular Disease: Ischemic Stroke PET-CT and PET-MRI in Neurology, 10.1007/978-3-319-31614-7_16, (251-262), . Iwata T (2015) Single-photon emission computed tomography and transcranial color-coded real-time sonography studies can predict hyperperfusion syndrome after carotid artery stenting, Cerebral Blood Flow and Metabolism (Japanese journal of cerebral blood flow and metabolism), 10.16977/cbfm.26.2_173, 26:2, (173-176), . Catana C, Drzezga A, Heiss W and Rosen B (2012) PET/MRI for Neurologic Applications, Journal of Nuclear Medicine, 10.2967/jnumed.112.105346, 53:12, (1916-1925), Online publication date: 1-Dec-2012. Dickson J, Ash T, Williams G, Sukstanskii A, Ansorge R and Yablonskiy D (2011) Quantitative phenomenological model of the BOLD contrast mechanism, Journal of Magnetic Resonance, 10.1016/j.jmr.2011.06.003, 212:1, (17-25), Online publication date: 1-Sep-2011. Catana C, Sorensen A and Rosen B (2011) Simultaneous PET and MR Imaging of the Human Brain Functional Neuroradiology, 10.1007/978-1-4419-0345-7_42, (867-892), . Dickson J, Ash T, Williams G, Harding S, Carpenter T, Menon D and Ansorge R (2010) Quantitative BOLD: The effect of diffusion, Journal of Magnetic Resonance Imaging, 10.1002/jmri.22151, 32:4, (953-961) Hoffman G and Ghanayem N (2010) Perioperative neuromonitoring in pediatric cardiac surgery: Techniques and targets, Progress in Pediatric Cardiology, 10.1016/j.ppedcard.2010.06.006, 29:2, (123-130), Online publication date: 1-Aug-2010. ZENONOS G and KIM J (2010) 18F-fluoromisonidazole PET/CT and Related Gauges of Cerebral Metabolism Identify Salvageable Tissue in Ischemic Penumbra Following Aneurysmal Subarachnoid Hemorrhage, Neurosurgery, 10.1227/01.neu.0000367839.75141.e6, 66:2, (N13-N15), Online publication date: 1-Feb-2010. Latchaw R, Alberts M, Lev M, Connors J, Harbaugh R, Higashida R, Hobson R, Kidwell C, Koroshetz W, Mathews V, Villablanca P, Warach S and Walters B (2009) Recommendations for Imaging of Acute Ischemic Stroke, Stroke, 40:11, (3646-3678), Online publication date: 1-Nov-2009. Yao H (2009) Acute Stroke Therapy: Highlighting the Ischemic Penumbra Brain Hypoxia and Ischemia, 10.1007/978-1-60327-579-8_16, (307-322), . Hossmann K and Traystman R (2008) Chapter 4 Cerebral blood flow and the ischemic penumbra Stroke, 10.1016/S0072-9752(08)01904-0, (67-92), . Jacobs A, Winkler A, Castro M and Lowenstein P (2005) Human gene therapy and imaging in neurological diseases, European Journal of Nuclear Medicine and Molecular Imaging, 10.1007/s00259-005-1960-3, 32:S2, (S358-S383), Online publication date: 1-Dec-2005. James M and Lunnon M (2005) Making Progress in the Acute Treatment of Stroke, International Journal of Pharmaceutical Medicine, 10.2165/00124363-200519020-00003, 19:2, (77-88), . Kelley R and Gonzalez‐Toledo E (2005) Stroke Neuroimaging, Part B, 10.1016/S0074-7742(05)67007-9, (203-238), . Hensel S, Rockstroh B, Berg P, Elbert T and Schönle P (2004) Left-hemispheric abnormal EEG activity in relation to impairment and recovery in aphasic patients, Psychophysiology, 10.1111/j.1469-8986.2004.00164x, 41:3, (394-400), Online publication date: 1-May-2004. Coles J (2004) Regional ischemia after head injury, Current Opinion in Critical Care, 10.1097/00075198-200404000-00008, 10:2, (120-125), Online publication date: 1-Apr-2004. October 2003Vol 34, Issue 10 Advertisement Article InformationMetrics https://doi.org/10.1161/01.STR.0000092396.70827.28PMID: 12970510 Originally publishedSeptember 11, 2003 Keywordscerebral blood flowpenumbratomography, emission computedstroke, ischemicPDF download Advertisement
Referência(s)